SQZ Biotech's main squeeze

SQZ Biotechnologies Co. has boosted its coffers with 2 awards totaling more than $300,000 for its CellSqueeze technology, a microfluidics-based platform that can deliver different bioactive materials directly into cells. The awards add to the company's $1 million in seed funding and the revenue it generates from academic clients and industrial partners, and they will help fund SQZ's own R&D.

According to Armon Sharei, SQZ cofounder and chairman and CellSqueeze co-inventor, "We now have 40 academic and industrial partners that are using the CellSqueeze platform and providing us with revenue."...